Forte Biosciences Balance Sheet (2016-2026) | FBRX

Balance Sheet Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
50.80M45.70M42.04M40.00M38.55M44.05M41.10M35.90M20.44M46.20M37.12M30.40M24.50M16.40M22.24M45.86M106.10M93.40M76.96M58.22M
Short-term Investments (Quarter)
9.99M36.12M
Cash & Current Investments (Quarter)
50.80M45.70M42.04M40.00M38.55M44.05M41.10M35.90M30.43M46.20M37.12M30.40M24.50M16.40M58.37M45.86M106.10M93.40M76.96M58.22M
Prepaid Assets (Quarter)
0.22M0.89M0.39M0.29M0.30M0.55M0.07M0.11M0.13M0.92M0.17M0.28M1.21M0.27M2.98M0.45M0.59M0.40M0.42M6.89M
Current Assets (Quarter)
51.88M46.56M42.52M40.41M38.85M44.59M41.51M36.27M30.75M47.10M38.33M31.50M25.71M17.67M61.35M47.16M107.62M95.41M80.59M65.11M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.07M0.03M0.10M0.11M0.11M0.10M0.09M0.08M0.12M0.11M0.15M0.13M0.11M
Other Non-Current Assets (Quarter)
0.01M0.83M0.79M0.89M0.01M0.01M0.49M0.01M0.41M0.05M0.05M0.06M0.06M0.06M0.14M0.03M0.03M0.03M2.06M2.00M
Non-Current Assets (Quarter)
1.01M0.83M0.79M0.89M0.87M0.53M0.49M0.44M0.44M0.78M0.65M0.52M0.37M0.28M0.21M0.30M0.17M1.68M2.19M2.11M
Assets (Quarter)
52.89M47.39M43.31M41.30M39.72M45.13M42.00M36.71M31.18M47.88M38.98M32.02M26.08M17.95M61.56M47.46M107.78M97.09M82.78M67.22M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.98M2.33M0.95M0.58M0.70M1.19M1.15M1.34M3.01M5.35M1.42M1.69M5.28M5.16M4.88M5.02M5.30M5.49M9.99M13.08M
Notes Payables (Quarter)
Payables (Quarter)
0.98M2.33M0.95M0.58M0.70M1.19M1.15M1.34M3.01M5.35M1.42M1.69M5.28M5.16M4.88M5.02M5.30M5.49M9.99M13.08M
Accumulated Expenses (Quarter)
1.99M0.77M0.68M0.68M0.45M0.64M2.03M2.42M0.59M2.12M0.95M1.65M3.84M3.42M1.55M1.25M0.93M7.50M10.76M10.56M
Other Accumulated Expenses (Quarter)
0.06M0.06M0.02M0.14M0.05M0.03M0.01M0.06M0.04M0.07M0.00M0.01M0.01M0.13M0.11M0.08M0.03M0.01M0.08M
Current Leases (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
2.98M3.74M1.76M1.26M1.51M2.29M3.18M3.76M6.30M7.47M3.67M3.33M9.12M8.58M9.08M9.03M9.17M12.99M20.75M23.65M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
Other Non-Current Liabilities (Quarter)
1.04M1.48M
Total Non-Current Liabilities (Quarter)
20.75M23.65M
Total Liabilities (Quarter)
2.98M3.74M1.76M1.26M1.51M2.29M3.18M3.76M6.30M7.47M3.67M3.33M9.12M8.58M9.08M9.03M9.17M12.99M21.79M25.12M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
49.91M43.65M41.55M40.05M38.21M42.84M38.82M32.95M24.88M40.41M35.31M28.68M16.96M9.37M52.48M38.43M98.61M84.10M60.99M42.10M
Shareholder's Equity (Quarter)
49.91M43.65M41.55M40.05M38.21M42.84M38.82M32.95M24.88M40.41M35.31M28.68M16.96M9.37M52.48M38.43M98.61M84.10M60.99M42.10M
Liabilities and Shareholders Equity (Quarter)
52.89M47.39M43.31M41.30M39.72M45.13M42.00M36.71M31.18M47.88M38.98M32.02M26.08M17.95M61.56M47.46M107.78M97.09M82.78M67.22M
Retained Earnings (Quarter)
-62.07M-69.82M-73.17M-75.70M-78.80M-82.20M-87.04M-93.80M-102.69M-112.60M0.00M-125.94M-138.50M-146.80M-154.00M-169.70M-180.90M-0.01M0.00M-245.50M
Treasury Shares (Quarter)
0.01M0.01M0.26M0.26M0.26M0.16M0.16M1.26M1.19M1.12M0.04M0.90M0.84M0.03M0.03M0.03M0.05M0.02M0.05M0.39M